Supernus Pharmaceuticals (SUPN) Pension (2011 - 2012)
Supernus Pharmaceuticals (SUPN) reported Pension of $279000.0 for Q4 2012, up 13.88% year-over-year from $245000.0 in Q1 2012, and up 1.45% quarter-over-quarter from $275000.0 in Q3 2012.
Supernus Pharmaceuticals (SUPN) Pension (2011 - 2012) Analysis & Trends
Supernus Pharmaceuticals (SUPN) has 2 years of Pension data on file, last reported at $279000.0 in Q4 2012.
- Pension for Q4 2012 came in at $279000.0, up 13.88% year-over-year; the trailing twelve-month figure through Dec 2012 was $279000.0 (up 13.88% YoY), and the FY2012 annual result was $279000.0, up 13.88% from the prior year.
- Pension improved to $279000.0 in Q4 2012 per SUPN's latest filing, from $275000.0 in the prior quarter.
- Over five years, Pension peaked at $279000.0 in Q4 2012 and troughed at $245000.0 in Q4 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Supernus Pharmaceuticals | 2.57 Bn | 2.19 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2012 | 279,000.00 |
| Sep 30, 2012 | 275,000.00 |
| Jun 30, 2012 | 259,000.00 |
| Mar 31, 2012 | 276,000.00 |
| Dec 31, 2011 | 245,000.00 |